nach oben

Acta Neuropathologica

Erschienen in:

01.09.2013 | Review

Hereditary spastic paraplegia: clinico-pathologic features and emerging molecular mechanisms

verfasst von: John K. Fink

Erschienen in: Acta Neuropathologica | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

Hereditary spastic paraplegia (HSP) is a syndrome designation describing inherited disorders in which lower extremity weakness and spasticity are the predominant symptoms. There are more than 50 genetic types of HSP. HSP affects individuals of diverse ethnic groups with prevalence estimates ranging from 1.2 to 9.6 per 100,000. Symptoms may begin at any age. Gait impairment that begins after childhood usually worsens very slowly over many years. Gait impairment that begins in infancy and early childhood may not worsen significantly. Postmortem studies consistently identify degeneration of corticospinal tract axons (maximal in the thoracic spinal cord) and degeneration of fasciculus gracilis fibers (maximal in the cervico-medullary region). HSP syndromes thus appear to involve motor-sensory axon degeneration affecting predominantly (but not exclusively) the distal ends of long central nervous system (CNS) axons. In general, proteins encoded by HSP genes have diverse functions including (1) axon transport (e.g. SPG30/KIF1A, SPG10/KIF5A and possibly SPG4/Spastin); (2) endoplasmic reticulum morphology (e.g. SPG3A/Atlastin, SPG4/Spastin, SPG12/reticulon 2, and SPG31/REEP1, all of which interact); (3) mitochondrial function (e.g. SPG13/chaperonin 60/heat-shock protein 60, SPG7/paraplegin; and mitochondrial ATP6); (4) myelin formation (e.g. SPG2/Proteolipid protein and SPG42/Connexin 47); (5) protein folding and ER-stress response (SPG6/NIPA1, SPG8/K1AA0196 (Strumpellin), SGP17/BSCL2 (Seipin), “mutilating sensory neuropathy with spastic paraplegia” owing to CcT5 mutation and presumably SPG18/ERLIN2); (6) corticospinal tract and other neurodevelopment (e.g. SPG1/L1 cell adhesion molecule and SPG22/thyroid transporter MCT8); (7) fatty acid and phospholipid metabolism (e.g. SPG28/DDHD1, SPG35/FA2H, SPG39/NTE, SPG54/DDHD2, and SPG56/CYP2U1); and (8) endosome membrane trafficking and vesicle formation (e.g. SPG47/AP4B1, SPG48/KIAA0415, SPG50/AP4M1, SPG51/AP4E, SPG52/AP4S1, and VSPG53/VPS37A). The availability of animal models (including bovine, murine, zebrafish, Drosophila, and C. elegans) for many types of HSP permits exploration of disease mechanisms and potential treatments. This review highlights emerging concepts of this large group of clinically similar disorders.

Abou Jamra R, Philippe O, Raas-Rothschild A et al (2011) Adaptor protein complex 4 deficiency causes severe autosomal-recessive intellectual disability, progressive spastic paraplegia, shy character, and short stature. Am J Hum Genet 88:788–795PubMed

Abou-áJamra R, Philippe O, Raas-Rothschild A et al (2011) Adaptor protein complex 4 deficiency causes severe autosomal-recessive intellectual disability, progressive spastic paraplegia, shy character, and short stature. Am J Hum Genet 88:788–795

Abou-Donia MB (1981) Organophosphorus ester-induced delayed neurotoxicity. Ann Rev Pharmacol Toxicol 21:511–548

Ahmed FE, Qureshi IM, Wooldridge MAW, Pejaver RK (1996) Hereditary spastic paraplegia and Evans’s syndrome. Acta Paediat 85:879–881PubMed

Al-Saif A, Bohlega S, Al-Mohanna F (2012) Loss of ERLIN2 function leads to juvenile primary lateral sclerosis. Ann Neurol 72:510–516PubMed

Al-Yahyaee S, Al-Gazali LI, De Jonghe P et al (2006) A novel locus for hereditary spastic paraplegia with thin corpus callosum and epilepsy. Neurology 66:1230–1234PubMed

Al-Yahyaee S, Al-Gazali LI, De JP et al (2006) A novel locus for hereditary spastic paraplegia with thin corpus callosum and epilepsy. Neurology 66:1230–1234PubMed

Alazami AM, Adly N, Al DH, Alkuraya FS (2011) A nullimorphic ERLIN2 mutation defines a complicated Hereditary Spastic Paraplegia locus (SPG18). Neurogenetics 12:333–336PubMed

Aldahmesh MA, Mohamed J, Alkuraya H et al (2011) Recessive mutations in ELOVL4 Cause ichthyosis, intellectual disability, and spastic quadriplegia. Am J Hum Genet 89:745–750PubMed

10.

Allan W, Herndon CN, Dudley FC (1944) Some examples of the inheritance of mental deficiency: apparently sex-linked idiocy and microcephaly. Am J Ment Defic 48:325–334

11.

Anderson FH (1979) Nerofibrillary degeneration on Guam. Brain 102:65–77PubMed

12.

Anheim M, Lagier-Tourenne C, Stevanin G et al (2009) SPG11 spastic paraplegia. A new cause of juvenile Parkinsonism. J Neurol 256:104–108PubMed

13.

Antonicka H, Oÿstergaard E, Sasarman F et al (2010) Mutations in C12orf65 in patients with encephalomyopathy and a mitochondrial translation defect. Am Journal Hum Genet 87:115–122

14.

Aparicio-Erriu IM, Prehn JH (2012) Molecular mechanisms in amyotrophic lateral sclerosis: the role of angiogenin, a secreted RNase. Front Neurosci 6:167PubMed

15.

Arnoldi A, Tonelli A, Crippa F et al (2008) A clinical, genetic, and biochemical characterization of SPG7 mutations in a large cohort of patients with hereditary spastic paraplegia. Hum Mutat 29:522–531PubMed

16.

Ashley-Koch A, Kail ME, Nance M, Gaskell P, Svenson I, Marchuck DA, Pericack-Vance MA, Zuchner S (2005) A new locus for autosomal dominant hereditary spastic paraplegia (SPG29) maps to chromosome. Am J Hum Genet 2:12

17.

Atkins J, Glynn P (2000) Membrane association of and critical residues in the catalytic domain of human neuropathy target esterase. J Biol Chem 275:24477–24483PubMed

18.

Atorino L, Silvestri L, Koppen M et al (2003) Loss of m-AAA protease in mitochondria causes complex I deficiency and increased sensitivity to oxidative stress in hereditary spastic paraplegia. J Cell Biol 163:777–787PubMed

19.

Auer-Grumbach M, Schlotter-Weigel B, Lochmuller H et al (2005) Phenotypes of the N88S Berardinelli-Seip congenital lipodystrophy 2 mutation. Ann Neurol 57:415–424PubMed

20.

Bakowska JC, Jenkins R, Pendleton J, Blackstone C (2005) The Troyer syndrome (SPG20) protein spartin interacts with Eps15. Biochem Biophys Res Comm 334(4):1042–1048PubMed

21.

Barlowe C (2009) Atlasin GTPases shape up ER networks. Dev Cell 17:157–158PubMed

22.

Bateman A, Jouet M, MacFarlane J, Du JS, Kenwrick S, Chothia C (1996) Outline structure of the human L1 cell adhesion molecule and the sites where mutations cause neurological disorders. EMBO J 15:6050–6059PubMed

23.

Bauer P, Leshinsky-Silver E, Blumkin L et al (2012) Mutation in the AP4B1 gene cause hereditary spastic paraplegia type 47 (SPG47). Neurogenetics 13:73–76PubMed

24.

Beetz C, Schule R, Deconinck T et al (2008) REEP1 mutation spectrum and genotype/phenotype correlation in hereditary spastic paraplegia type 31. Brain 131:1078–1086PubMed

25.

Behan W, Maia M (1974) Strumpell’s familial spastic paraplegia: genetics and neuropathology. J Neurol Neurosurg Psychiatry 37:8–20PubMed

26.

Behrends C, Sowa ME, Gygi SP, Harper JW (2010) Network organization of the human autophagy system. Nature 466:68–76PubMed

27.

Bettencourt da Cruz A, Wentzell J, Kretzschmar D (2008) Swiss cheese, a protein involved in progressive neurodegeneration, acts as a noncanonical regulatory subunit for PKA-C3. J Neurosci 28:10885–10892PubMed

28.

Bialer MG, Lawrence L, Stevenson RE et al (1992) Allan-Herndon-Dudley syndrome: clinical and linkage studies on a second family. Am J Med Genet 43:491–497PubMed

29.

Bian X, Klemm RW, Liu TY et al (2011) Structures of the atlastin GTPase provide insight into homotypic fusion of endoplasmic reticulum membranes.In: Proceedings of National Academy of Sciences of USA

30.

Biancheri R, Ciccolella M, Rossi A et al (2009) White matter lesions in spastic paraplegia with mutations in SPG5/CYP7B1. Neuromuscul Disord 19:62–65PubMed

31.

Bien-Willner R, Sambuughin N, Holley H, Bodensteiner J, Sivakumar K (2006) Childhood-onset spastic paraplegia with NIPA1 gene mutation. J Child Neurol 21:974–977PubMed

32.

Blair MA, Ma S, Hedera P (2006) Mutation in KIF5A can also cause adult-onset hereditary spastic paraplegia. Neurogenetics 7:47–50PubMed

33.

Blumen SC, Bevan S, Abu-Mouch S et al (2003) A locus for complicated hereditary spastic paraplegia maps to chromosome 1q24-q32. Ann Neurol 54:796–803PubMed

34.

Blumkin L, Lerman-Sagie T, Lev D, Yosovich K, Leshinsky-Silver E (2011) A new locus (SPG47) maps to 1p13.2-1p12 in an Arabic family with complicated autosomal recessive hereditary spastic paraplegia and thin corpus callosum. J Neurol Sci 305:67–70PubMed

35.

Botzolakis EJ, Zhao J, Gurba KN, Macdonald RL, Hedera P (2011) The effect of HSP-causing mutations in SPG3A and NIPA1 on the assembly, trafficking, and interaction between atlastin-1 and NIPA1. Mol Cell Neurosci 46:122–135PubMed

36.

Bouhouche A, Benomar A, Bouslam N, Chkili T, Yahyaoui M (2006) Mutation in the epsilon subunit of the cytosolic chaperonin-containing t-complex peptide-1 (Cct5) gene causes autosomal recessive mutilating sensory neuropathy with spastic paraplegia. J Med Genet 43:441–443PubMed

37.

Bouhouche A, Benomar A, Bouslam N, Ouazzani R, Chkili T, Yahyaoui M (2006) Autosomal recessive mutilating sensory neuropathy with spastic paraplegia maps to chromosome 5p15.31-14.1. Eur J Hum Genet 14:249–252PubMed

38.

Boukhris A, Feki I, Elleuch N et al (2010) A new locus (SPG46) maps to 9p21.2-q21.12 in a Tunisian family with a complicated autosomal recessive hereditary spastic paraplegia with mental impairment and thin corpus callosum. Neurogenetics 11:441–448PubMed

39.

Bouslam N, Benomar A, Azzedine H et al (2005) Mapping of a new form of pure autosomal recessive spastic paraplegia (SPG28). Ann Neurol 57:567–571PubMed

40.

Bross P, Naundrup S, Hansen J et al (2008) The Hsp60-(p.V98I) mutation associated with hereditary spastic paraplegia SPG13 compromises chaperonin function both in vitro and in vivo. J Biol Chem 283:15694–15700PubMed

41.

Browman DT, Resek ME, Zajchowski LD, Robbins SM (2006) Erlin-1 and erlin-2 are novel members of the prohibitin family of proteins that define lipid-raft-like domains of the ER. J Cell Sci 119:3149–3160PubMed

42.

Brugman F, Scheffer H, Wokke JHJ et al (2008) Paraplegin mutations in apparently sporadic adult-onset upper motor neuron syndromes. Neurology 71:1500–1505PubMed

43.

Buge A, Escourolle R, Rancurel G, Gray F, Pertuiset BF (1979) Strumpell-Lorrains familial spasmodic paraplegia - anatomical and clinical review and report on a new case. Rev Neurol (Paris) 135:329–337

44.

Burger J, Metzke H, Paternotte C, Schilling F, Hazan J, Reis A (1996) Autosomal dominant spastic paraplegia with anticipation maps to a 4-cM interval on chromosome 2p21-p24 in a large German family. Hum Genet 98:371–375PubMed

45.

Byrne PC, Webb S, McSweeney F, Burke T, Hutchinson M, Parfrey N (1998) Linkage of AD HSP and cognitive impairment to chromosome 2p: haplotype and phenotype analysis indicates variable expression and low or delayed penetrance. Eur J Hum Genet 6:275–282PubMed

46.

Cambi F, Tang XM, Cordray P, Fain PR, Keppen LD, Barker DF (1996) Refined genetic mapping and proteolipid protein mutation analysis in X-linked pure hereditary spastic paraplegia. Neurology 46:1112–1117PubMed

47.

Casari G, Fusco M, Ciarmatori S et al (1998) Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell 93:973–983PubMed

48.

Charvin D, Fonknechten N, Cifuentes-Diaz C, Joshi V, Hazan J, Melki J, Betuing S (2003) Mutations in SPG4 are responsible for a loss of function of spastin, an abundant neuronal protein localized to the nucleus. Am J Hum Genet 12:71–78

49.

Chen S, Song C, Guo H, Xu P, Huang W et al (2005) Distinct novel mutations affecting the same base in the NIPA1 gene cause autosomal dominant hereditary spastic paraplegia in two Chinese families. Hum Mutat 25:135–141PubMed

50.

Clemen CS, Tangavelou K, Strucksberg KH et al (2010) Strumpellin is a novel valosin-containing protein binding partner linking hereditary spastic paraplegia to protein aggregation diseases. Brain 133:2920–2941PubMed

51.

Connell JW, Lindon C, Luzio JP, Reid E (2009) Spastin couples microtubule severing to membrane traffic in completion of cytokinesis and secretion. Traffic 10:42–56PubMed

52.

Criscuolo C, Filla A, Coppola G et al (2009) Two novel CYP7B1 mutations in Italian families with SPG5: a clinical and genetic study. J Neurol 256:1252–1257PubMed

53.

Crosby AH, Patel H, Patton MA, Proukakis C, Cross H (2002) Spartin, the Troyer syndrome gene, suggests defective endosomal trafficking underlies some forms of hereditary spastic paraplegia. Am J Hum Genet 71:516 (Ref Type: Abstract)

54.

Cross HE, McKusick VA (1967) The Troyer syndrome. A recessive form of spastic paraplegia with distal muscle wasting. Arch Neurol 16:473–485PubMed

55.

Dalpozzo F, Rossetto MG, Boaretto MS et al (2003) Infancy onset hereditary spastic paraplegia associated with a novel atlastin mutation. Neurology 61:580–581PubMed

56.

de Bot ST, van de Warrenburg BP, Kremer HP, Willemsen MA (2010) Child neurology: hereditary spastic paraplegia in children. Neurology 75:e75–e79PubMed

57.

De Laurenzi V, Rogers GR, Hamrock DJ, Marekov LN, Steinert PM, Compton JG, Markova N, Rizzo WB (1996) Sjögren-Larsson syndrome is caused by mutations in the fatty aldehyde dehydrogenase gene. Nat Genet 12(1):52–57PubMed

58.

Dell’Angelica EC, Mullins C, Bonifacino JS (1999) AP-4, a novel protein complex related to clathrin adaptors. J Biol Chem 274:7278–7285PubMed

59.

Deluca GC, Ebers GC, Esiri MM (2004) The extent of axonal loss in the long tracts in hereditary spastic paraplegia. Neuropathol Appl Neurobiol 30:576–584PubMed

60.

DeMichele G, DeFusco M, Cavalcanti F et al (1998) A new locus for autosomal recessive hereditary spastic paraplegia maps to chromosome 16q24.3. Am J Hum Genet 63:135–139

61.

Dennis SC, Green NE (1988) Hereditary spastic paraplegia. J Pediatr Orthop 8:413–417PubMed

62.

Dick KJ, Al-Mjeni R, Baskir W et al (2008) A novel locus for an autosomal recessive hereditary spastic paraplegia (SPG35) maps to 16q21-q23. Neurology 71:248–252PubMed

63.

Dick KJ, Eckhardt M, Paisan-Ruiz C et al (2010) Mutation of FA2H underlies a complicated form of hereditary spastic paraplegia (SPG35). Hum Mutat 31:E1251–E1260PubMed

64.

Du J, Hu YC, Tang BS et al (2011) Expansion of the phenotypic spectrum of SPG6 caused by mutation in NIPA1. Clin Neurol Neurosurg 113:480–482PubMed

65.

Dudek BR, Richardson RJ (1982) Evidence for the existence of neurotoxic esterase in neural and lymphatic tissue of the adult hen. Biochem Pharmacol 31:1117–1121PubMed

66.

Durr A, Brice A, Serdaru M et al (1994) The phenotype of “pure” autosomal dominant spastic paraplegia. Neurology 44:1274–1277PubMed

67.

Durr A, Davoine C-S, Paternotte C et al (1996) Phenotype of autosomal dominant spastic paraplegia linked to chromosome 2. Brain 119:1487–1496PubMed

68.

Dursun U, Koroglu C, Kocasoy OE, Ugur SA, Tolun A (2009) Autosomal recessive spastic paraplegia (SPG45) with mental retardation maps to 10q24.3-q25.1. Neurogenetics 10:325–331PubMed

69.

Evans K, Keller C, Gasgow K, Conn B, Lauring B (2006) Interaction of two hereditary spastic paraplegia gene products, spastin and atlastin, suggests a common pathway for axonal maintenance. Proc Natl Acad Sci (USA) 103:10666–10671

70.

Evans KJ, Gomes ER, Reisenweber SM, Gundersen GG, Lauring BP (2005) Linking axonal degeneration to microtubule remodeling by Spastin-mediated microtubule severing. J Cell Biol 168:599–606PubMed

71.

Fassier C, Hutt JA, Scholpp S et al (2010) Zebrafish atlastin controls motility and spinal motor axon architecture via inhibition of the BMP pathway. Nat Neurosci 13:1380–1387PubMed

72.

Feinstein M, Markus B, Noyman I et al (2010) Pelizaeus-Merzbacher-like disease caused by AIMP1/p43 homozygous mutation. Am J Hum Genet 87:820–828PubMed

73.

Ferreirinha F, Quattrini A, Pirozzi M et al (2004) Axonal degeneration in paraplegin-deficient mice is associated with abnormal mitochondria and impairment of axonal transport. J Clin Invest 113:231–242PubMed

74.

Fichera M, Lo Giudice M, Falco M et al (2004) Evidence of kinesin heavy chain (KIF5A) involvement in pure hereditary spastic paraplegia. Neurology 63:1108–1110PubMed

75.

Fink JK (2011) In: Rimoin D (ed) Hereditary spastic paraplegia. Churchill LivingstoneElsevier, Philadelphia

76.

Fink JK (2007) Hereditary Spastic Paraplegias. In: Schapira AHV (ed) Neurology and clinical neurosciences. Mosby Elsevier, Philadelphia, pp 899–910

77.

Fink JK, Sharp G, Lange B et al (1995) Autosomal dominant hereditary spastic paraparesis, type I: clinical and genetic analysis of a large North American family. Neurology 45:325–331PubMed

78.

Fink JK, Wu C-TB, Jones SM et al (1995) Autosomal dominant familial spastic paraplegia: tight linkage to chromosome 15q. Am J Hum Genet 56:188–192PubMed

79.

Fontaine B, Davoine C-S, Durr A et al (2000) A new locus for autosomal dominant pure spastic paraplegia, on chromosome 2q24-q34. Am J Hum Genet 66:702–707PubMed

80.

Franca MC Jr, D’Abreu A, Maurer-Morelli CV et al (2007) Prospective neuroimaging study in hereditary spastic paraplegia with thin corpus callosum. Mov Disord 22:1556–1562PubMed

81.

Fujita Y, Fujii T, Nishio A, Tuboi K, Tsuji K, Nakamura M (1990) Familial case of May-Hegglin anomaly associated with familial spastic paraplegia. Am J Hematol 35:219–221PubMed

82.

Garner CC, Garner A, Huber G, Kozak C, Matus A (1990) Molecular cloning of microtubule-associated protein 1 (MAP1A) and microtubule-associated protein 5 (MAP1B): identification of distinct genes and their differential expression in developing brain. J Neurochem 55:146–154PubMed

83.

Gillooly DJ, Simonsen A, Stenmark H (2001) Cellular functions of phosphatidylinositol 3-phosphate and FYVE domain proteins. Biochem J 355:249–258PubMed

84.

Glynn P (1999) Neuropathy target esterase. Biochem J 344:625–631PubMed

85.

Glynn P (2000) Neural development and neurodegeneration: two faces of neuropathy target esterase. Prog Neurobiol 61:61–74PubMed

86.

Guelly C, Zhu PP, Leonardis L et al (2011) Targeted high-throughput sequencing identifies mutations in atlastin-1 as a cause of hereditary sensory neuropathy type I. Am J Hum Genet 88:99–105PubMed

87.

Haberlova J, Claeys KG, Zamecnik J, De JP, Seeman P (2008) Extending the clinical spectrum of SPG3A mutations to a very severe and very early complicated phenotype. J Neurol 255:927–928PubMed

88.

Hanein S, Durr A, Ribai P et al (2007) A novel locus for autosomal dominant ‘uncomplicated’ hereditary spastic paraplegia maps to chromosome 8p21.1-q13.3. Hum Genet 122:261–273PubMed

89.

Hanein S, Martin E, Boukhris A et al (2008) Identification of the SPG15 gene, encoding spastizin, as a frequent cause of complicated autosomal-recessive spastic paraplegia, including Kjellin syndrome. Am J Hum Genet 82:992–1002PubMed

90.

Hanna MC, Blackstone C (2009) Interaction of the SPG21 protein ACP33/maspardin with the aldehyde dehydrogenase ALDH16A1. Neurogenetics 10:217–228PubMed

91.

Hansen J, Corydon TJ, Palmfeldt J et al (2008) Decreased expression of the mitochondrial matrix proteases Lon and ClpP in cells from a patient with hereditary spastic paraplegia (SPG13). Neuroscience 153:474–482PubMed

92.

Hansen JJ, Durr A, Cournu-Rebeix I et al (2002) Hereditary spastic paraplegia SPG13 is associated with a muatation in the gene encoding the mitochondrial chaperonin Hsp60. Am J Hum Genet 70:1328–1332PubMed

93.

Harding AE (1993) Hereditary spastic paraplegias. Semin Neurol 13:333–336PubMed

94.

Harding AE (1983) Classification of the hereditary ataxias and paraplegias. Lancet 1:1151–1155PubMed

95.

Hazan J, Fontaine B, Bruyn RPM et al (1994) Linkage of a new locus for autosomal dominant familial spastic paraplegia to chromosome 2p. Hum Mol Genet 3:1569–1573PubMed

96.

Hazan J, Lamy C, Melki J, Munnich A, de Recondo J, Weissenbach J (1993) Autosomal dominant familial spastic paraplegia is genetically heterogeneous and one locus maps to chromosome 14q. Nat Genet 5:163–167PubMed

97.

Hedera P, DiMauro S, Bonilla E, Wald J, Eldevik OP, Fink JK (1999) Phenotypic analysis of autosomal dominant hereditary spastic paraplegia linked to chromosome 8q. Neurology 53:44–50PubMed

98.

Hedera P, Eldevik OP, Maly P, Rainier S, Fink JK (2005) Spinal cord magnetic resonance imaging in autosomal dominant hereditary spastic paraplegia. Neuroradiology 47:730–734PubMed

99.

Hedera P, Rainier S, Alvarado D et al (1999) Novel locus for autosomal dominant hereditary spastic paraplegia on chromosome 8q. Am J Hum Genet 64:563–569PubMed

100.

Hentati A, Pericack-Vance MA, Hung W-Y, Belal S, Laing N, Boustani RM, Hentati F, Hamida MB, Siddique T (1994) Linkage of the “pure” recessive familial spastic paraplegia to chromosome 8 markers and evidence of genetic locus heterogeneity. Hum Genet 3:1263–1267

101.

Hentati A, Pericak-Vance MA, Lennon F et al (1994) Linkage of the late onset autosomal dominant familial spastic paraplegia to chromosome 2p markers. Hum Mol Genet 3:1867–1871PubMed

102.

Hirst J, Barlow D, Francisco GC et al (2011) The fifth adaptor protein complex. PLoS Biol 9:e1001170PubMed

103.

Hirst J, Irving C, Borner GH (2013) Adaptor protein complexes AP-4 and AP-5: new players in endosomal trafficking and progressive spastic paraplegia. Traffic 14(2):153–164PubMed

104.

Hirst J, Bright NA, Rous B, Robinson MS (1999) Characterization of a fourth adaptor-related protein complex. Mol Biol Cell 10:2787–2802PubMed

105.

Hodgkinson CA, Bohlega S, Abu-Amero SN et al (2002) A novel form of autosomal recessive pure hereditary spastic paraplegia maps to chromosome 13q14. Neurology 59:1905–1909PubMed

106.

Hooper C, Puttamadappa SS, Loring Z, Shekhtman A, Bakowska JC (2010) Spartin activates atrophin-1-interacting protein 4 (AIP4) E3 ubiquitin ligase and promotes ubiquitination of adipophilin on lipid droplets. BMC Biol 8:72PubMed

107.

Hudson LD (2003) Pelizaeus-Merzbacher disease and spastic paraplegia type 2: two faces of myelin loss from mutations in the same gene. J Child Neurol 18:616–624PubMed

108.

Hughes CA, Byrne PC, Webb S et al (2001) SPG15, a new locus for autosomal recessive complicated HSP on chromosome 14q. Neurology 56:1230–1233PubMed

109.

Ito D, Fujisawa T, Iida H, Suzuki N (2008) Characterization of seipin/BSCL2, a protein associated with spastic paraplegia 17. Neurobiol Dis 31:266–277PubMed

110.

Ito D, Suzuki N (2007) Seipin/BSCL2-related motor neuron disease: seipinopathy is a novel conformational disease associated with endoplasmic reticulum stress. Rinsho Shinkeigaku 47:329–335PubMed

111.

Ito D, Suzuki N (2009) Seipinopathy: a novel endoplasmic reticulum stress-associated disease. Brain 132:8–15PubMed

112.

Ivanova N, Claeys KG, Deconinck T et al (2007) Hereditary spastic paraplegia 3A associated with axonal neuropathy. Arch Neurol 64:706–713PubMed

113.

Jagell S, Gustavson KH, Holmgren G (1981) Sjogren–Larsson syndrome in Sweden: a clinical, genetic and epidemiological study. Clin Genet 19:233–256PubMed

114.

Jagell S, Linden S (1982) Ichtyosis in the Sjogren–Larsson syndrome. Clin Genet 21:243–252PubMed

115.

Jia D, Gomez TS, Metlagel Z et al (2010) WASH and WAVE actin regulators of the Wiskott-Aldrich syndrome protein (WASP) family are controlled by analogous structurally related complexes. Proc Natl Acad Sci USA 107:10442–10447PubMed

116.

Johnson MK (1974) The primary biochemical lesion leading to the delayed neurotoxic effects of some organophosphorus esters. J Neurochem 23:785–789PubMed

117.

Johnson MK, Glynn P (2001) Neuropathy target esterase. In: Krieger RI (ed) Handbook of pesticide toxicology. Academic Press, San Diego, pp 953–965

118.

Jouet M, Rosenthal A, Armstrong G et al (1994) X-linked spastic paraplegia (SPG1), MASA syndrome and X-linked hydrocephalus result from mutations in the L1 gene. Nat Genet 7:402–407PubMed

119.

Kasher PR, De Vos KJ, Wharton SB et al (2009) Direct evidence for axonal transport defects in a novel mouse model of mutant spastin-induced hereditary spastic paraplegia (HSP) and human HSP patients. J Neurochem 110:34–44PubMed

120.

Kenwrick S, Watkins A, De Angelis E (2000) Neural cell recognition molecule L1: relating biological complexity to human disease mutations. Hum Mol Gen 9:879–886PubMed

121.

Khateeb S, Flusser H, Ofir R et al (2006) PLA2G6 mutation underlies infantile neuroaxonal dystrophy. Am J Hum Genet 79:942–948PubMed

122.

Kisanuki YY, Rainier S, Moore J, Saunders T, Wilkinson JE, Fink JK (2008) Animal model of SPG6 hereditary spastic paraplegia. Am J Hum Genet: 1794/T

123.

Klebe S, Azzedine H, Durr A et al (2006) Autosomal recessive spastic paraplegia (SPG30) with mild ataxia and sensory neuropathy maps to chromosome 2q37.3. Brain 129:1456–1462

124.

Klebe S, Lossos A, Azzedine H et al (2012) KIF1A missense mutations in SPG30, an autosomal recessive spastic paraplegia: distinct phenotypes according to the nature of the mutations. Eur J Hum Genet 20:645–649PubMed

125.

Kobayashi H, Hoffman EP, Marks HG (1994) The rumpshaker mutation in spastic paraplegia. Nature Genet 7:351–352PubMed

126.

Krabbe K, Nielsen JE, Fallentin E, Fenger K, Herning M (1997) MRI of autosomal dominant pure spastic paraplegia. Neuroradiology 39:724–727PubMed

127.

Kruer MC, Paisan-Ruiz C, Boddaert N et al (2010) Defective FA2H leads to a novel form of neurodegeneration with brain iron accumulation (NBIA). Ann Neurol 68:611–618PubMed

128.

Kurian MA, Morgan NV, MacPherson L, Foster K, Peake D, Gupta R, Philip SG, Hendriksz C, Morton JEV, Kingston HM, Rosser EM, Wassmer E, Gissen P, Maher ER (2008) Phenotypic spectrum of neurodegeneration associated with mutations in the PLA2G6 gene (PLAN). Neurology 70:1623–1629PubMed

129.

Kuru S, Sakai M, Konagaya M, Yoshida M, Hashizume Y (2005) Autopsy case of hereditary spastic paraplegia with thin corpus callosum showing severe gliosis in the cerebral white matter. Neuropathology 25:346–352PubMed

130.

Lamari F, Mochel F, Sedel F, and Saudubray JM (2012) Disorders of phospholipids, sphingolipids and fatty acids biosynthesis: toward a new category of inherited metabolic diseases. J Inherit Metab Dis: 1–15

131.

Lee JA, Gao FB (2012) Neuronal functions of ESCRTs. Exp Neurobiol 21:9–15PubMed

132.

Lin P, Li J, Liu Q et al (2008) A missense mutation in SLC33A1, which encodes the acetyl-CoA transporter, causes autosomal-dominant spastic paraplegia (SPG42). Am J Hum Genet 83:752–759PubMed

133.

Lin P, Mao F, Liu Q, Shao C, Yan C, Gong Y (2010) Prenatal diagnosis of autosomal dominant hereditary spastic paraplegia (SPG42) caused by SLC33A1 mutation in a Chinese kindred. Prenat Diagn 30:485–486PubMed

134.

Lind GE, Raiborg C, Danielsen SA et al (2011) SPG20, a novel biomarker for early detection of colorectal cancer, encodes a regulator of cytokinesis. Oncogene 30:3967–3978PubMed

135.

Lo KY, Kuzmin A, Unger SM, Petersen JD, Silverman MA (2011) KIF1A is the primary anterograde motor protein required for the axonal transport of dense-core vesicles in cultured hippocampal neurons. Neuro Lett 491:168–173

136.

Lu J, Rashid F, Byrne PC (2006) The hereditary spastic paraplegia protein spartin localises to mitochondria. J Neurochem 98:1908–1919PubMed

137.

Lynex C, Carr I, Leek J et al (2004) Homozygosity for a missense mutation in the 67 kDa isoform of glutamate decarboxylase in a family with autosomal recessive spastic cerebral palsy: parallels with Stiff-Person Syndrome and other movement disorders. BMC Neurology 4:20PubMed

138.

Macedo-Souza LI, Kok F, Santos S et al (2005) Spastic paraplegia, optic atrophy, and neuropathy is linked to chromosome 11q13. Ann Neurol 57:730–737PubMed

139.

Macedo-Souza LI, Kok F, Santos S et al (2008) Reevaluation of a large family defines a new locus for X-linked recessive pure spastic paraplegia (SPG34) on chromosome Xq25. Neurogenetics 9:225–226PubMed

140.

Magre J, Delepine M, Khallouf E et al (2001) Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13. Nat Genet 28:365–370PubMed

141.

Maltecca F, Magnoni R, Cerri F, Cox GA, Quattrini A, Casari G (2009) Haploinsufficiency of AFG3L2, the gene responsible for spinocerebellar ataxia type 28, causes mitochondria-mediated Purkinje cell dark degeneration. J Neurosci 29:9244–9254PubMed

142.

Mannan AU, Krawen P, Sauter SM et al (2006) ZFYVE27 (SPG33), a novel spastin-binding protein, is mutated in hereditary spastic paraplegia. Am J Hum Genet 79:351–357PubMed

143.

Maranduba CM, Friesema EC, Kok F et al (2006) Decreased cellular uptake and metabolism in Allan-Herndon-Dudley syndrome (AHDS) due to a novel mutation in the MCT8 thyroid hormone transporter. J Med Genet 43:457–460PubMed

144.

Martinez-Lage M, Molina-Porcel L, Falcone D et al (2012) TDP-43 pathology in a case of hereditary spastic paraplegia with a NIPA1/SPG6 mutation. Acta Neuropathol 124:285–291PubMed

145.

Martinez-Murillo F, Kobayashi H, Pegoraro E et al (1999) Genetic localization of a new locus for recessive spastic paraplegia to 15q13-15. Neurology 53:50–56PubMed

146.

Marx J (1991) Alzheimer’s research moves to mice. Science 253:266–267PubMed

147.

Mattiazzi M, Vijayvergiya C, Gajewski CD et al (2004) The mtDNA T8993G (NARP) mutation results in an impairment of oxidative phosphorylation that can be improved by antioxidants. Hum Mol Genet 13:869–879PubMed

148.

McDermott CJ, Dayaratne RK, Tomkins J et al (2001) Paraplegin gene analysis in hereditary spastic paraparesis (HSP) pedigrees in northeast England. Neurology 56:467–471PubMed

149.

McHale DP, Mitchell S, Bundey S et al (1999) A gene for autosomal recessive symmetrical spastic cerebral palsy maps to chromosome 2q24-25. Am J Hum Genet 64:526–532PubMed

150.

Meijer IA, Cossette P, Roussel J, Benard M, Toupin S, Rouleau GA (2004) A novel locus for pure recessive hereditary spastic paraplegia maps to 10q22.1-10q24.1. Ann Neurol 56:579–582PubMed

151.

Meilleur KG, Traore M, Sangare M et al (2010) Hereditary spastic paraplegia and amyotrophy associated with a novel locus on chromosome 19. Neurogenetics 11:313–318PubMed

152.

Meyer T, Schwan A, Dullinger JS et al (2005) Early-onset ALS with long-term survival associated with spastin gene mutation. Neurology 65:141–143PubMed

153.

Micheli F, Cersosimo MG, Zuniga RC (2006) Hereditary spastic paraplegia associated with dopa-responsive Parkinsonism. Mov Disord 21:716–717PubMed

154.

Milewska M, McRedmond J, Byrne PC (2009) Identification of novel spartin-interactors shows spartin is a multifunctional protein. J Neurochem 111:1022–1030PubMed

155.

Ming L, Rainier S, Mathay J, and Fink JK (2005) Hereditary spastic paraplegia with incomplete genetic penetrance and genetic anticipation. (Manuscript submitted to Neurology, 2005)

156.

Mitchell S, Bundey S (1997) Symmetry of neurological signs in Pakistani patients with probable inherited spastic cerebral palsy. Clin Genet 51(1):7–14PubMed

157.

Montenegro G, Rebelo AP, Connell J et al (2012) Mutations in the ER-shaping protein reticulon 2 cause the axon-degenerative disorder hereditary spastic paraplegia type 12. J Clin Invest 122:538–544PubMed

158.

Moreno-De-Luca A, Helmers SL, Mao H et al (2011) Adaptor protein complex-4 (AP-4) deficiency causes a novel autosomal recessive cerebral palsy syndrome with microcephaly and intellectual disability. J Med Genet 48:141–144PubMed

159.

Mroue RM, El-Sabban ME, Talhouk RS (2011) Connexins and the gap in context. Integr Biol (Camb) 3:255–266

160.

Muglia M, Criscuolo C, Magariello A et al (2004) Narrowing of the critical region in autosomal recessive spastic paraplegia linked to the SPG5 locus. Neurogenetics 5:49–54PubMed

161.

Murphy S, Gorman G, Beetz C et al (2009) Dementia in SPG4 hereditary spastic paraplegia: clinical, genetic, and neuropathologic evidence. Neurology 73:378–384PubMed

162.

Najmabadi H, Hu H, Garshasbi M et al (2011) Deep sequencing reveals 50 novel genes for recessive cognitive disorders. Nature 478:57–63PubMed

163.

Nielsen JE, Johnsen B, Koefoed P et al (2004) Hereditary spastic paraplegia with cerebellar ataxia: a complex phenotype associated with a new SPG4 gene mutation. Eur J Neurol 11:817–824PubMed

164.

Nielsen JE, Koefoed P, Abell K et al (1997) CAG repeat expansion in autosomal dominant pure spastic paraplegia linked to chromosome 2p21-p24. Hum Mol Genet 6:1811–1816PubMed

165.

Nimityongskul P, Anderson LD, Sri P (1992) Hereditary spastic paraplegia. Orthop Rev 21:643–646PubMed

166.

Nomura H, Koike F, Tsuruta Y, Iwaki A, Iwaki T (2001) Autopsy case of autosomal recessive hereditary spastic paraplegia with reference to the muscular pathology. Neuropathology 21:212–217PubMed

167.

Orlacchio A, Babalini C, Borreca A et al (2010) SPATACSIN mutations cause autosomal recessive juvenile amyotrophic lateral sclerosis. Brain 133:591–598PubMed

168.

Orlacchio A, Gaudiello F, Totaro A et al (2004) A new SPG4 mutation in a variant form of spastic paraplegia with congenital arachnoid cysts. Neurology 62:1875–1878PubMed

169.

Orlacchio A, Kawarai T, Totaro A et al (2004) Hereditary spastic paraplegia: clinical genetic study of 15 families. Arch Neurol 61:849–855PubMed

170.

Orlacchio A, Montieri P, Babalini C, Gaudiello F, Bernardi G, Kawarai T (2011) Late-onset hereditary spastic paraplegia with thin corpus callosum caused by a new SPG3A mutation. J Neurol 258:1361–1363PubMed

171.

Orlacchio A, Patrono C, Gaudiello F et al (2008) Silver syndrome variant of hereditary spastic paraplegia: a locus to 4p and allelism with SPG4. Neurology 70:1959–1966PubMed

172.

Orthmann-Murphy JL, Salsano E, Abrams CK et al (2009) Hereditary spastic paraplegia is a novel phenotype for GJA12/GJC2 mutations. Brain 132:426–438PubMed

173.

Oz-Levi D, Ben-Zeev B, Ruzzo E et al (2012) Mutation in TECPR2 reveals a role for autophagy in hereditary spastic paraparesis. Am J Hum Genet 91:1065–1072PubMed

174.

Park SH, Zhu P–P, Parker RL, Blackstone C (2010) Hereditary spastic paraplegia proteins REEP1, spastin, and atlastin-1 coordinate microtubule interactions with the tubular ER network. J Clin Invest 120:1097–1110PubMed

175.

Park SH, Zhu PP, Parker RL, Blackstone C (2010) Hereditary spastic paraplegia proteins REEP1, spastin, and atlastin-1 coordinate microtubule interactions with the tubular ER network. J Clin Invest 120:1097–1110PubMed

176.

Patel H, Cross H, Proukakis C et al (2002) SPG20 is mutated in Troyer syndrome, an hereditary spastic paraplegia. Nat Genet 31:347–348PubMed

177.

Patel H, Hart PE, Warner TT et al (2001) The silver syndrome variant of hereditary spastic paraplegia maps to chromosome 11q12-q14, with evidence for genetic heterogeneity within this subtype. Am J Hum Genet 69:209–215PubMed

178.

Paternotte C, Rudnicki D, Fizames C et al (1998) Quality assessment of whole genome mapping data in the refined familial spastic paraplegia interval on chromosome 14q. Genome Res 8:1216–1227PubMed

179.

Pratt AJ, Getzoff ED, Perry JJP (2012) Amyotrophic lateral sclerosis: update and new developments. Degener Neurol Neuromuscular Dis 2:1–14

180.

Proukakis C, Cross H, Patel H, Patton MA, Valentine A, Crosby AH (2004) Troyer syndrome revisited. A clinical and radiological study of a complicated hereditary spastic paraplegia. J Neurol 251:1105–1110PubMed

181.

Rainier S, Bui M, Mark E et al (2008) Neuropathy target esterase gene mutations cause motor neuron disease. Am J Hum Genet 82:780–785PubMed

182.

Rainier S, Chai J-H, Tokarz D, Nicholls RD, Fink JK (2003) NIPA1 gene mutations cause autosomal dominant hereditary spastic paraplegia (SPG6). Am J Hum Genet 73:967–971PubMed

183.

Rainier S, Fink JK (2005) Hereditary spastic paraplegia: clinical features and animal models. In: Ledoux M (ed) Animal models of movement disorders. Elseivier Academic Press, New York, pp 687–690

184.

Rainier S, Sher C, Reish O, Thomas D, Fink JK (2006) De novo occurrence of novel SPG3A/atlastin mutation presenting as cerebral palsy. Arch Neurol 63:445–447PubMed

185.

Raskind WH, Pericak-Vance MA, Lennon F, Wolff J, Lipe HP, Bird TD (1997) Familial spastic paraparesis: evaluation of locus heterogeneity, anticipation and haplotype mapping of the SPG4 locus on the short arm of chromosome 2. Am J Hum Genet 74:26–36

186.

Reddy PL, Seltzer WK, Grewal RP (2007) Possible anticipation in hereditary spastic paraplegia type 4 (SPG4). Can J Neurol Sci 34:208–210PubMed

187.

Reid E, Connell J, Edwards S, Duley S, Brown SE, Sanderson CM (2005) The hereditary spastic paraplegia protein spastin interacts with the ESCRT-III complex-associated endosomal protein CHMP1B. Hum Mol Gen 14:19–38PubMed

188.

Reid E, Dearlove AM, Osborn M, Rogers T, Rubinsztein DC (2000) A locus for autosomal dominant “Pure” hereditary spastic paraplegia maps to chromosome 19q13. Am J Hum Genet 66:728–732PubMed

189.

Reid E, Dearlove AM, Rhodes M, Rubinsztein DC (1999) A new locus for autosomal dominant ‘pure’ hereditary spastic paraplegia mapping to chromosome 12q13 and evidence for further genetic heterogeneity. Am J Hum Genet 65:757–763PubMed

190.

Reid E, Grayson C, Rubinsztein DC, Rogers MT, Rubinsztein JS (1999) Subclinical cognitive impairment in autosomal dominant ‘pure’ hereditary spastic paraplegia. J Med Genet 36:797–798PubMed

191.

Ribai P, Stevanin G, Bouslam N et al (2006) A new phenotype linked to SPG27 and refinement of the critical region on chromosome. J Neurol 253:714–719PubMed

192.

Richardson RJ, Davis CS, Johnson MK (1979) Subcellular distribution of marker enzymes and of neurotoxic esterase in adult hen brain. J Neurochem 32:607–615PubMed

193.

Rismanchi N, Soderblom C, Stadler J, Zhu P–P, Blackstone C (2008) Atlastin GTPases are required for Golgi apparatus and ER morphogenesis. Hum Mol Gen 17:1591–1604PubMed

194.

Roll-Mecak A, Vale RD (2005) The drosophila homologue of the hereditary spastic paraplegia protein, spastin, severs and disassembles microtubules. Curr Biol 15:650–655PubMed

195.

Roll-Mecak A, Vale RD (2008) Structural basis of microtubule severing by the hereditary spastic paraplegia protein spastin. Nature 451:363–367PubMed

196.

Ropers F, Derivery E, Hu H et al (2011) Identification of a novel candidate gene for non-syndromic autosomal recessive intellectual disability: the WASH complex member SWIP. Hum Mol Genet 20:2585–2590PubMed

197.

Sack GH, Huether CA, Garg N (1978) Familial spastic paraplegia: clinical and pathologic studies in a large kindred. Johns Hopkins Med J 143:117–121PubMed

198.

Sanderson CM, Connell JW, Edwards TL et al (2006) Spastin and atlastin, two proteins mutated in autosomal dominant hereditary spastic paraplegia, are binding partners. Hum Mol Gen 15:307–318PubMed

199.

Sargiannidou I, Markoullis K, Kleopa KA (2010) Molecular mechanisms of gap junction mutations in myelinating cells. Histol Histopathol 25:1191–1206PubMed

200.

Saugier-Veber P, Munnich A, Bonneau D et al (1994) X-linked spastic paraplegia and Pelizaeus-Merzbacher disease are allelic disorders at the proteolipid protein locus. Nature Genet 6:257–262PubMed

201.

Schlipf NA, Beetz C, Schule R et al (2010) A total of 220 patients with autosomal dominant spastic paraplegia do not display mutations in the SLC33A1 gene (SPG42). Eur J Hum Genet 18:1065–1067PubMed

202.

Schule R, Bonin M, Durr A et al (2009) Autosomal dominant spastic paraplegia with peripheral neuropathy maps to chr12q23-24. Neurology 72:1893–1898PubMed

203.

Schuurs-Hoeijmakers J, Geraghty M, Kamsteeg EJ et al (2012) Mutations in DDHD2, encoding an intracellular phospholipase A1, cause a recessive form of complex hereditary spastic paraplegia. Am J Hum Genet 91:1073–1081PubMed

204.

Schwarz GA (1952) Hereditary (familial) spastic paraplegia. AMA Arch Neurol Psychiatry 68:655–682PubMed

205.

Schwarz GA, Liu C-N (1956) Hereditary (familial) spastic paraplegia. Further clinical and pathologic observations. AMA Arch Neurol Psychiatry 75:144–162PubMed

206.

Seri M, Cusano R, Forabosco P et al (1999) Genetic mapping to 10q23.3-q24.2, in a large Italian pedigree, of a new syndrome showing bilateral cataracts, gastroesophageal reflux, and spastic paraparesis with amyotrophy. Am J Hum Genet 64:586–593PubMed

207.

Shimazaki H, Takiyama Y, Ishiura H et al (2012) A homozygous mutation of C12orf65 causes spastic paraplegia with optic atrophy and neuropathy (SPG55). J Med Genet 49:777–784PubMed

208.

Simpson MA, Cross H, Proukakis C et al (2003) Maspardin is mutated in Mast syndrome, a complicated form of hereditary spastic paraplegia associated with dementia. Am J Hum Genet 73:1147–1156PubMed

209.

Slabicki M, Theis M, Krastev DB et al (2010) A genome-scale DNA repair RNAi screen identifies SPG48 as a novel gene associated with hereditary spastic paraplegia. PLoS Biol 8:e1000408PubMed

210.

Sperfeld AD, Baumgartner A, Kassubek J (2005) Magnetic resonance investigation of the upper spinal cord in pure and complicated hereditary spastic paraparesis. Eur Neurol 54:181–185PubMed

211.

Sporkrl O, Uschkureit T, Bussow H, Stoffel W (2002) Oligodendrocytes expressing exclusively the DM20 isoform of the proteolipid protein gene: myelination and development. Glia 37:19–30

212.

Steinmuller R, Lantingua-Cruz A, Carcia-Garcia R, Kostrzewa M, Steinberger D, Muller U (1997) Evidence of a third locus in X-linked recessive spastic paraplegia [letter]. Hum Genet 100:287–289PubMed

213.

Stevanin G, Santorelli FM, Azzedine H et al (2007) Mutations in SPG11, encoding spatacsin, are a major cause of spastic paraplegia with thin corpus callosum. Nature Genet 39:366–372PubMed

214.

Subramony SH, Nguyen TV, Langford L, Lin X, Parent AD, Zhang J (2009) Identification of a new form of autosomal dominant spastic paraplegia. Clin Genet 76:113–116PubMed

215.

Suzuki SO, Iwaki T, Arakawa K, Furuya H, Fujii N, Iwaki A (2011) An autopsy case of adult-onset hereditary spastic paraplegia type 2 with a novel mutation in exon 7 of the proteolipid protein 1 gene. Acta Neuropathol 122:755–781

216.

Svenstrup K, Moller RS, Christensen J, Budtz-Jorgensen E, Gilling M, Nielsen JE (2013) NIPA1 mutation in complex hereditary spastic paraplegia with epilepsy. Eur J Neurol 18:1197–1199

217.

Tamagaki A, Shima M, Tomita R et al (2000) Segregation of a pure form of spastic paraplegia and NOR insertion into Xq11.2. Am J Med Genet 94:5–8PubMed

218.

Tang BS, Chen X, Zhao GH et al (2004) Clinical features of hereditary spastic paraplegia with thin corpus callosum: report of 5 Chinese cases. Chin Med J (Engl) 117:1002–1005

219.

Tesson C, Nawara M, Salih M et al (2012) Alteration of fatty-acid-metabolizing enzymes affects mitochondrial form and function in hereditary spastic paraplegia. Am J Hum Genet 91:1051–1064PubMed

220.

Thomsen B, Nissen PH, Agerholm JS, Bendixen C (2010) Congenital bovine spinal dysmyelination is caused by a missense mutation in the SPAST gene. Neurogenetics 11:175–183PubMed

221.

Tsang HT, Edwards TL, Wang X et al (2009) The hereditary spastic paraplegia proteins NIPA1, spastin and spartin are inhibitors of mammalian BMP signalling. Hum Mol Genet 18:3805–3821PubMed

222.

Tsaousidou MK, Ouahchi K, Warner TT et al (2008) Sequence alterations within CYP7B1 implicate defective cholesterol homeostasis in motor-neuron degeneration. Am J Hum Genet 82:510–515PubMed

223.

Tuck RR, O’Neill BP, Gharib H, Mulder DW (1983) Familial spastic paraplegia with Kallmann’s syndrome. J Neurol, Neurosurg, Psych 46:671–674

224.

Uttner I, Baumgartner A, Sperfeld AD, Kassubek J (2007) Cognitive performance in pure and complicated hereditary spastic paraparesis: a neuropsychological and neuroimaging study. Neurosci Lett 419:158–161PubMed

225.

Valdmanis PN, Meijer IA, Reynolds A et al (2007) Mutations in the KIAA0196 gene at the SPG8 locus cause hereditary spastic paraplegia. Am J Hum Genet 80:152–161PubMed

226.

Valente EM, Brancati F, Caputo V, Patrono C, Costanti D, Dallapiccola B (2002) Novel locus for autosomal dominant pure heredtiary spastic paraplegia (SPG19) maps to chromosome 9q22-q34. Ann Neurol 51:681–685PubMed

227.

Vassilopoulos D, Spengos M, Zoumbou V, Scarpalezos S (1981) The spinal canal in famlial spastic paraplegia. Eur Neurol 20:110–114PubMed

228.

Vazza GZM, Boaretto F, Micaglio GF, Sartori V, Mostacciuolo ML (2000) A new locus for autosomal recessive spastic paraplegia associated with mental retardation and distal motor neuropathy SPG14, maps to chromosome 3q27–q28. Am J Hum Genet 67:504–509PubMed

229.

Verkerk AJ, Schot R, Dumee B et al (2009) Mutation in the AP4M1 gene provides a model for neuroaxonal injury in cerebral palsy. Am J Hum Genet 85:40–52PubMed

230.

Verny C, Guegen N, Desquiret V et al (2011) Hereditary spastic paraplegia-like disorder due to a mitochondrial ATP6 gene point mutation. Mitochondrion 11:70–75PubMed

231.

Vose SC, Fujioka K, Gulevich AG, Lin AY, Holland NT, Casida JE (2008) Cellular function of neuropathy target esterase in lysophosphatidylcholine action. Toxicol Appl Pharmacol 232:376–383PubMed

232.

Wakabayashi K, Kobayashi H, Kawasaki S, Kondo H, Takahashi H (2001) Autosomal recessive spastic paraplegia with hypoplastic corpus callosum, multisystem degeneration and ubiquitinated eosinophilic granules. Acta Neuropathol 101:69–73PubMed

233.

Wang G, Liu G, Wang X et al (2012) ERLIN2 promotes breast cancer cell survival by modulating endoplasmic reticulum stress pathways. BMC Cancer 12:225PubMed

234.

Warnecke T, Duning T, Schirmacher A et al (2010) A novel splice site mutation in the SPG7 gene causing widespread fiber damage in homozygous and heterozygous subjects. Mov Disord 25:413–420PubMed

235.

Webb S, Coleman D, Byrne P et al (1998) Autosomal dominant hereditary spastic paraparesis with cognitive loss linked to chromosome 2p. Brain 121:601–609PubMed

236.

Wharton SB, McDermott CJ, Grierson AJ et al (2003) The cellular and molecular pathology of the motor system in hereditary spastic paraparesis due to mutation of the spastin gene. J Neuropathol Exp Neurol 62:1166–1177PubMed

237.

White KD, Ince PG, Lusher M et al (2000) Clinical and pathologic findings in hereditary spastic paraparesis with spastin mutation. Neurology 55:89–94PubMed

238.

Wild NJ, Rosenbloom L (1986) Familial cerebral palsy associated with normal intelligence. Postgrad Med J 62:827–830PubMed

239.

Wilkinson PA, Crosby AH, Turner C et al (2003) A clinical and genetic study of SPG5A linked autosomal recessive hereditary spastic paraplegia. Neurology 61:235–238PubMed

240.

Wilkinson PA, Simpson MA, Bastaki L et al (2005) A new locus for autosomal recessive complicated hereditary spastic paraplegia (SPG26) maps to chromosome 12p11.1–12q14. J Med Genet 42:80–82PubMed

241.

Windpassinger C, Auer-Grumbach M, Irobi J et al (2004) Heterozygous missense mutations in BSCL2 are associated with distal hereditary motor neuropathy and Silver syndrome. Nat Genet 36:271–276PubMed

242.

Winner B, Uyanik G, Gross C et al (2004) Clinical progression and genetic analysis in hereditary spastic paraplegia with thin corpus callosum in spastic gait gene 11 (SPG11). Arch Neurol 61:117–121PubMed

243.

Winrow CJ, Hemming ML, Allen DM, Quistad GB, Casida JE, Barlow C (2003) Loss of neuropathy target esterase in mice links organophosphate exposure to hyperactivity. Nature Genet 33:477–485PubMed

244.

Woehrer A, Laszlo L, Finsterer J et al (2012) Novel crystalloid oligodendrogliopathy in hereditary spastic paraplegia. Acta Neuropathol 124:583–591PubMed

245.

Xia CH, Roberts EA, Her LS et al (2003) Abnormal neurofilament transport caused by targeted disruption of neuronal kinesin heavy chain K1F5A. J Cell Biol 161:55–66PubMed

246.

Yamashita A, Kumazawa T, Koga H, Suzuki N, Oka S, Sugiura T (2010) Generation of lysophosphatidylinositol by DDHD domain containing 1 (DDHD1): possible involvement of phospholipase D/phosphatidic acid in the activation of DDHD1. Biochimica et Biophysica Acta (BBA)—Mol Cell Biol Lipids 1801:711–720

247.

Zaccheo O, Dinsdale D, Meacock PA, Glynn P (2004) Neuropathy target esterase and its yeast homologue degrade phosphatidylcholine to glycerophosphocholine in living cells. J Bio Chem 279:24024–24033

248.

Zhang L (2010) CRASH syndrome: does it teach us about neurotrophic functions of cell adhesion molecules? Neuroscientist 16:470–474PubMed

249.

Zhao GH, Hu ZM, Shen L et al (2008) A novel candidate locus on chromosome 11p14.1-p11.2 for autosomal dominant hereditary spastic paraplegia. Chin Med J (Engl) 121:430–434

250.

Zhao J, Matthies DS, Botzolakis EJ, Macdonald RL, Blakely RD, Hedera P (2008) Hereditary spastic paraplegia-associated mutations in the NIPA1 gene and its Caenorhabditis elegans homolog trigger neural degeneration in vitro and in vivo through a gain-of-function mechanism. J Neurosci 28:13938–13951PubMed

251.

Zhao X, Alvarado D, Rainier S et al (2001) Mutations in a novel GTPase cause autosomal dominant hereditary spastic paraplegia. Nat Genet 29:326–331PubMed

252.

Zhu PP, Soderblom C, Tao-Cheng J-H, Stadler J, Blackstone C (2006) SPG3A protein atlastin-1 is enriched in growth cones and promotes axon elongation during neuronal development. Human Mol Gen 15:1343–1353

253.

Zivony-Elboum Y, Westbroek W, Kfir N et al (2012) A founder mutation in Vps37A causes autosomal recessive complex hereditary spastic paraparesis. J Med Genet 49:462–472PubMed

254.

Zortea M, Vettori A, Trevisan CP et al (2002) Genetic mapping of a susceptibility locus for disc herniation and spastic paraplegia on 6q23.3-q24.1. J Med Genet 39:387–390PubMed

255.

Zuchner S, Kail ME, Nance M et al (2006) A new locus for dominant hereditary spastic paraplegia maps to chromosome 2p12. Neurogenetics 7:127–129PubMed

256.

Zuchner S, Wang G, Tran-Viet KN et al (2006) Mutations in the novel mitochondrial protein REEP1 cause hereditary spastic paraplegia type 31. Am J Hum Genet 79:365–369PubMed

Titel: Hereditary spastic paraplegia: clinico-pathologic features and emerging molecular mechanisms
verfasst von: John K. Fink
Publikationsdatum: 01.09.2013
Verlag: Springer Berlin Heidelberg
Erschienen in: Acta Neuropathologica / Ausgabe 3/2013
Print ISSN: 0001-6322
Elektronische ISSN: 1432-0533
DOI: https://doi.org/10.1007/s00401-013-1115-8

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

18.04.2024 | Arterielle Hypertonie | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Hereditary spastic paraplegia: clinico-pathologic features and emerging molecular mechanisms

Abstract

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

Manche Gestagene können das Risiko für Meningeome erhöhen

Parkinson: Größere Studie bestätigt Genauigkeit von Hauttest

Update Neurologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2013

Reduced cholinergic olfactory centrifugal inputs in patients with neurodegenerative disorders and MPTP-treated monkeys

Non-Alzheimer neurodegenerative pathologies and their combinations are more frequent than commonly believed in the elderly brain: a community-based autopsy series

ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosis

Modeling key pathological features of frontotemporal dementia with C9ORF72 repeat expansion in iPSC-derived human neurons

Sporadic ALS with compound heterozygous mutations in the SQSTM1 gene

The Alzheimer’s β-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

Manche Gestagene können das Risiko für Meningeome erhöhen

Parkinson: Größere Studie bestätigt Genauigkeit von Hauttest

Update Neurologie